252 related articles for article (PubMed ID: 12432281)
1. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.
Fukuhara H; Kuramochi M; Fukami T; Kasahara K; Furuhata M; Nobukuni T; Maruyama T; Isogai K; Sekiya T; Shuin T; Kitamura T; Reeves RH; Murakami Y
Jpn J Cancer Res; 2002 Jun; 93(6):605-9. PubMed ID: 12079507
[TBL] [Abstract][Full Text] [Related]
6. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
7. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
[TBL] [Abstract][Full Text] [Related]
8. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of tumor suppressor genes by promoter methylation is important in the pathogenesis of pancreatic cancer.
Fleming JB; Minna JD
Cancer Biol Ther; 2002; 1(3):297-9. PubMed ID: 12432282
[No Abstract] [Full Text] [Related]
11. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Fukushima N; Sato N; Ueki T; Rosty C; Walter KM; Wilentz RE; Yeo CJ; Hruban RH; Goggins M
Am J Pathol; 2002 May; 160(5):1573-81. PubMed ID: 12000709
[TBL] [Abstract][Full Text] [Related]
12. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Omura N; Vincent A; Li A; Knight S; Yu J; Hruban RH; Goggins M
Clin Cancer Res; 2012 Feb; 18(3):700-12. PubMed ID: 22173550
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation of the 5' upstream region of Tslc1 gene in hamster pancreatic tumors.
Shimizu K; Onishi M; Sugata E; Fujii H; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2007 Feb; 353(2):522-6. PubMed ID: 17187758
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms.
Martin ST; Sato N; Dhara S; Chang R; Hustinx SR; Abe T; Maitra A; Goggins M
Cancer Biol Ther; 2005 Jul; 4(7):728-33. PubMed ID: 15970691
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
Xu S; Furukawa T; Kanai N; Sunamura M; Horii A
J Hum Genet; 2005; 50(4):159-167. PubMed ID: 15824892
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]